Manouchehri, Navid
74  Ergebnisse:
Personensuche X
?
1

Cladribine tablets after treatment with natalizumab (CLADRI..:

Sguigna, Peter V. ; Hussain, Rehana Z. ; Okai, Annette...
Therapeutic Advances in Neurological Disorders.  17 (2024)  - p. , 2024
 
?
 
?
 
?
8

To the editors: Impact of mass vaccination on SARS-CoV-2 in..:

Tugemann, Bastian ; Manouchehri, Navid ; Stuve, Olaf
Multiple Sclerosis and Related Disorders.  59 (2022)  - p. 103541 , 2022
 
?
10

The sequential natalizumab – alemtuzumab therapy in patient..:

Hussain, Rehana Z ; Sguigna, Peter V ; Okai, Annette...
Journal of Central Nervous System Disease.  14 (2022)  - p. 117957352211239 , 2022
 
?
11

Should ocrelizumab be used in non-active primary progressiv..:

Manouchehri, Navid ; Stüve, Olaf
Therapeutic Advances in Neurological Disorders.  14 (2021)  - p. 175628642199050 , 2021
 
?
12

Choroid plexus volumetrics and brain inflammation in multip..:

Manouchehri, Navid ; Stüve, Olaf
Proceedings of the National Academy of Sciences.  118 (2021)  40 - p. , 2021
 
?
13

CD11c+CD88+CD317+myeloid cells are critical mediators of pe..:

Manouchehri, Navid ; Hussain, Rehana Z. ; Cravens, Petra D....
Proceedings of the National Academy of Sciences.  118 (2021)  14 - p. , 2021
 
1-15